Correction: γδ T cells in immunotherapies for B-cell malignancies - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Amendment: The Role of γδ T Cells in Immunotherapy Approaches for B-cell Malignancies

  • By

  • Léa Rimailho

  • Carla Faria

  • Marcin Domagala

  • Camille Laurent

  • Christine Bezombes

  • Mary Poupot

  • August 17, 2026

Share

Objective:

To correct and clarify the role of γδ T cells in immunotherapy for B-cell malignancies.

Approach:
  • Correction of Activation Mechanisms: The correction highlights that γδ T cell activation is influenced by CD3, CD2, CD226, and adhesion molecules like LFA-1.
  • Figure Update: Figure 1 has been updated to illustrate the activation mechanisms of γδ T cells.
Key Findings:
  • γδ T cell activation involves additional molecules beyond CD3 and CD2.
  • CD226 and adhesion molecules like LFA-1 enhance γδ T cell immune responses.
Interpretation:

The correction provides a more comprehensive understanding of the activation mechanisms of γδ T cells.

Conclusion:

The authors acknowledge Théo Nouailhetas for his contributions to improving the manuscript.

Sources:

Original Source(s)

Related Content